Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Privia Health Group Inc (NASDAQ: PRVA) closed at $21.85 in the last session, up 1.30% from day before closing price of $21.57. In other words, the price has increased by $1.30 from its previous closing price. On the day, 0.51 million shares were traded. PRVA stock price reached its highest trading level at $22.1 during the session, while it also had its lowest trading level at $21.305.
Ratios:
We take a closer look at PRVA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.21 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.03. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $23.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $23 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 10 ’24 when Mehrotra Parth sold 135,142 shares for $18.50 per share. The transaction valued at 2,500,127 led to the insider holds 247,771 shares of the business.
Mehrotra Parth bought 135,142 shares of PRVA for $2,500,719 on Sep 10 ’24. On Jun 11 ’24, another insider, Boehler Adam, who serves as the Director of the company, bought 364 shares for $16.50 each. As a result, the insider paid 6,006 and bolstered with 5,773,522 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2622021888 and an Enterprise Value of 2253505536. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 213.38, and their Forward P/E ratio for the next fiscal year is 85.15. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53 while its Price-to-Book (P/B) ratio in mrq is 4.26. Its current Enterprise Value per Revenue stands at 1.313 whereas that against EBITDA is 110.672.
Stock Price History:
The Beta on a monthly basis for PRVA is 0.85, which has changed by 0.03552568 over the last 52 weeks, in comparison to a change of 0.22677135 over the same period for the S&P500. Over the past 52 weeks, PRVA has reached a high of $23.24, while it has fallen to a 52-week low of $15.92. The 50-Day Moving Average of the stock is 4.10%, while the 200-Day Moving Average is calculated to be 15.21%.
Shares Statistics:
According to the various share statistics, PRVA traded on average about 698.60K shares per day over the past 3-months and 610180 shares per day over the past 10 days. A total of 119.95M shares are outstanding, with a floating share count of 106.24M. Insiders hold about 11.47% of the company’s shares, while institutions hold 97.28% stake in the company. Shares short for PRVA as of 1735603200 were 5774753 with a Short Ratio of 8.27, compared to 1732838400 on 5687613. Therefore, it implies a Short% of Shares Outstanding of 5774753 and a Short% of Float of 7.71.
